Now Playing

Competitor Permitted To Sell Lipitor Generic

Drugmaker Pfizer lost the patent on its blockbuster drug Lipitor on Wednesday. And on the same day, regulators granted an Indian company approval to sell a generic version of the cholesterol drug in the U.S. market.

Trouble listening? See our technical support page.